David Daniel Ambrose’s TG United Eyes Major Pharmaceuticals Product…
Pending a green light from the FDA, Florida pharmaceuticals manufacturer will begin collecting new applications from other drug companies, says CEO David Daniel Ambrose.
(PRWeb April 17, 2012)
Read the full story at http://www.prweb.com/releases/david-daniel-ambrose/david-daniel-ambrose/prweb9373282.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.